The latest price target for MetLife (NYSE:MET) was reported by Morgan Stanley on March 3, 2026. The analyst firm set a price target for $93.00 expecting MET to rise to within 12 months (a possible 34.33% upside). 37 analyst firms have reported ratings in the last year.

The latest analyst rating for MetLife (NYSE:MET) was provided by Morgan Stanley, and MetLife maintained their overweight rating.

The last upgrade for MetLife Inc happened on January 8, 2024 when Goldman Sachs raised their price target to $80. Goldman Sachs previously had a neutral for MetLife Inc.

The last downgrade for MetLife Inc happened on September 19, 2025 when Piper Sandler changed their price target from $84 to $84 for MetLife Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MetLife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MetLife was filed on March 3, 2026 so you should expect the next rating to be made available sometime around March 3, 2027.

While ratings are subjective and will change, the latest MetLife (MET) rating was a maintained with a price target of $101.00 to $93.00. The current price MetLife (MET) is trading at is $69.23, which is out of the analyst’s predicted range.